WHO ICTRP trial

Randomized, Open, Single-Dose, Two-Agent, Two-Cycle, Double-Crossover Fasting…

ChiCTR2300073540 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2300073540
Public title Randomized, Open, Single-Dose, Two-Agent, Two-Cycle, Double-Crossover Fasting and Postprandial State Bioequivalence Trial of Sildenafil Citrate Dispersible Tablets in Healthy Subjects
Scientific title Randomized, Open, Single-Dose, Two-Agent, Two-Cycle, Double-Crossover Fasting and Postprandial State Bioequivalence Trial of Sildenafil Citrate Dispersible Tablets in Healthy Subjects
Primary sponsor Huzhou Central Hospital
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Phase 1
Countries China
Conditions Healthy subjects
Interventions Fasting R-T group:Subjects take one tablet of R medication in the first cycle and one tablet of T medication in the second cycle on an empty stomach;Fasting T-R group:Subjects take one tablet of T medication in the first cycle and one…
Registration date Jul 13, 2023
Target size Fasting R-T group:24;Fasting T-R group:24;Postprandial T-R group:28;Postprandial…
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations